Related Experiment Video
Updated: Nov 6, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Improving Medication Adherence Through Adaptive Digital Interventions (iMedA) in Patients With Hypertension: Protocol
Kobra Etminani1, Carina Göransson2, Alexander Galozy1
1Center for Applied Intelligent Systems Research, Halmstad University, Halmstad, Sweden.
This study introduces iMedA, an AI-powered mobile app designed to improve medication adherence and blood pressure control in hypertensive patients. The digital intervention aims to reduce healthcare costs by enhancing patient self-care management.
Area of Science:
- Digital Health
- Artificial Intelligence in Medicine
- Cardiovascular Disease Management
Background:
- Hypertension affects 27% of Swedes, with suboptimal blood pressure control in half of treated patients.
- Poor medication adherence (MA) in hypertension increases hospitalization costs and risks of heart disease, stroke, and heart failure.
- Improving MA is crucial for effective hypertension management and better clinical outcomes.
Purpose of the Study:
- To design, develop, test, and evaluate iMedA, an adaptive digital intervention delivered via mobile app.
- To enhance medication adherence (MA), self-care management, and blood pressure control in hypertensive individuals.
- To explore the potential of AI-driven tools in supporting clinical treatment for hypertension.
Main Methods:
- An interrupted time series design will be employed for data collection and analysis.
- Daily data will be collected for 14 days pre-intervention, during 6 months of app use, and 14 days post-intervention.
- Segmented regression analysis will assess the intervention's impact on MA and blood pressure, informed by a needs assessment including systematic reviews and focus groups.
Main Results:
- Needs assessment via focus groups in the Swedish context is complete.
- Digital intervention design and development are ongoing, with planned completion by November 2020.
- A 2-week pilot usability study is scheduled, followed by the main interrupted time series study starting February 2021.
Conclusions:
- iMedA is hypothesized to significantly improve medication adherence and self-care management in hypertensive patients.
- Digital self-care management tools can serve as valuable adjuncts to clinical treatment.
- The iMedA intervention aims to support patients without increasing the burden on healthcare staff.
Related Concept Videos
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Errors occurring during blood pressure monitoring
Several factors...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Heart Failure V: Medical Management
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...

